CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 102 filers reported holding CYTEK BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $41,339 | -27.7% | 7,489 | +11.8% | 0.00% | -33.3% |
Q2 2023 | $57,184 | -1.1% | 6,696 | +6.4% | 0.00% | 0.0% |
Q1 2023 | $57,814 | -20.1% | 6,291 | -11.2% | 0.00% | 0.0% |
Q4 2022 | $72,317 | -30.6% | 7,083 | 0.0% | 0.00% | -40.0% |
Q3 2022 | $104,262 | +37.2% | 7,083 | 0.0% | 0.01% | +66.7% |
Q2 2022 | $76,001 | +9.9% | 7,083 | +10.4% | 0.00% | +50.0% |
Q1 2022 | $69,154 | -13.2% | 6,415 | +31.5% | 0.00% | +100.0% |
Q4 2021 | $79,625 | -23.8% | 4,879 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $104,459 | – | 4,879 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 2,100,000 | $30,912,000 | 12.48% |
Miura Global Management | 820,000 | $12,070,000 | 7.24% |
RA Capital Management | 13,381,054 | $196,969,000 | 4.20% |
HHLR ADVISORS, LTD. | 8,757,030 | $128,903,000 | 3.39% |
Brown Capital Management | 4,406,461 | $64,863,000 | 0.91% |
Perceptive Advisors | 1,289,534 | $18,982,000 | 0.55% |
Hillsdale Investment Management Inc. | 344,529 | $5,072,000 | 0.46% |
PURA VIDA INVESTMENTS, LLC | 527,164 | $7,760,000 | 0.45% |
Parkwood LLC | 42,336 | $623,000 | 0.09% |
PDT Partners, LLC | 31,436 | $463,000 | 0.07% |